Shanghai HyaMab Biotech Co.,Ltd.
3 clinical trials · Sponsor
◉ Watch Shanghai HyaMab Biotech Co.,Ltd.
| Record | Firm | Date |
|---|---|---|
| PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor (NCT05801237) | Shanghai HyaMab Biotech Co.,Ltd. | 2023-09-21 |
| HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours (NCT04914351) | Shanghai HyaMab Biotech Co.,Ltd. | 2022-05-03 |
| PE0116 Injection in Treatment of Patients With Advanced Solid Tumours (NCT05800249) | Shanghai HyaMab Biotech Co.,Ltd. | 2021-03-08 |
Track Shanghai HyaMab Biotech Co.,Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.